BBVA
GBT

Banco Bilbao Vizcaya Argentaria’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,000
Closed -$315K – 790
2020
Q2 		$315K Buy
+5,000
New +$343K 0.01% 621
2020
Q1 		– Sell
-3,000
Closed -$238K – 776
2019
Q4 		$238K Buy
+3,000
New +$178K 0.01% 651

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's GBT Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 5,000 shares — an estimated $315K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in GBT in Q4 2019 and held it in 2 quarters. The position peaked at $315K in Q2 2020. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 5,000 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $315K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 2 quarters.
  • Banco Bilbao Vizcaya Argentaria's Global Blood Therapeutics, Inc. position peaked at $315K in Q2 2020.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.